When a woman tells me she feels like a stranger in her own skin, I ask her to map her month. The story often appears in patterns. A sharp dip in patience six days before bleeding. Elbows aching after a week of broken sleep. A sudden return of humor after day three of the period. At 38, those patterns may widen. At 48, some months look like a flat line of symptoms punctuated by spikes of heat that climb from chest to scalp. By 58, the hot flashes may fade but the joints protest each morning and sex feels more like friction than intimacy. Hormone therapy is not a magic eraser, but used with care, it is one of the most effective tools for restoring function and quality of life from PMS to menopause and the years that follow.
I work at the intersection of internal medicine and women’s health, and I have seen hormone treatment change a patient’s week - and sometimes her trajectory. The trick is matching biology to goals. “Hormone balance therapy” is a promise you will see on billboards for a hormone clinic. In a good office, that means careful listening, targeted testing, and calibrated dosing. In a bad one, it can mean a pellet inserted under the skin that drives testosterone past male ranges and leaves you with cystic acne and a headache of regret for six months. You deserve the former.
The physiology that drives the symptoms
Estrogen and progesterone do more than regulate periods. Estradiol engages receptors in the brain, bones, skin, vasculature, and pelvic tissues. Progesterone modulates GABA receptors, influences sleep architecture, and stabilizes the endometrium. Testosterone, present at a fraction of male levels, supports sexual desire, energy, and musculoskeletal integrity. Thyroid hormone sets the metabolic tempo. Cortisol provides stress response and circadian alignment. When those actors shift, the entire play online hormone therapy reads differently.
Premenstrual symptoms appear when progesterone and estradiol fall in the late luteal phase. For some, that decline, paired with underlying neurotransmitter sensitivity, leads to PMDD - a severe, cyclical mood disorder that deserves the same seriousness as major depression. In perimenopause, ovulation becomes irregular. Progesterone often drops first, estradiol can spike then crash, and bleeding becomes unpredictable. Menopause is a final ovarian shutdown, defined by 12 months without a period. Estradiol and progesterone both remain low thereafter, and the vasomotor, genitourinary, and skeletal effects become the main issues.
When testing helps - and when it does not
I order labs when the result will change the plan. During the reproductive years, hormone levels swing by orders of magnitude across the month. A random estradiol reading on day 11 rarely clarifies PMS. For cyclic symptoms, the most useful tests are often nonhormonal - ferritin if bleeding is heavy, TSH if fatigue feels out of proportion, a pregnancy test if cycles skip, and a CBC if dizziness joins the picture.
When a specific question is on the table, targeted hormone testing makes sense. For example, in perimenopause, FSH can be high one month and normal the next, which limits its value as a single diagnostic marker. In early postmenopause, an elevated FSH with low estradiol aligns with symptoms and supports a menopause treatment plan. If libido is the focus, total and free testosterone along with SHBG help set a baseline before any testosterone therapy. For acne or hair changes, DHEA-S can be useful. For thyroid concerns, TSH with reflex free T4 is the backbone, with free T3 in selected cases. For suspected hyperprolactinemia, a fasting morning prolactin clarifies. If someone presents with classic Cushingoid features, I skip casual cortisol checks and order validated screening like late-night salivary cortisol or a low-dose dexamethasone suppression test.
Salivary and dried spot sex hormone tests are marketed heavily in “hormone wellness” circles. Outside of specific applications like the circadian cortisol profile, they add little to routine decision-making for HRT. Blood tests, while imperfect, remain the clinical standard for hormone levels treatment when labs are needed at all.
First tools for PMS and PMDD
PMS management starts with predictable basics because they move the needle. Regular aerobic activity, 7 to 9 hours of sleep, protein and fiber in the first half of the day, and attention to iron if periods are heavy reduce symptom amplitude for many. Magnesium glycinate 200 to 400 mg at night is well tolerated and helps with cramps and sleep for a subset. For PMDD, cognitive behavioral therapy and SSRIs - either continuous or luteal phase only - have strong evidence. Certain combined oral contraceptives that stabilize hormones across the cycle can help mood and bleeding. When a patient wants “natural hormone therapy,” I explain that bioidentical progesterone can smooth the late luteal drop for some, but dosing and timing matter. In practice, a low nightly dose in the second half of the cycle can aid sleep and reduce anxiety, particularly in those with coexisting perimenopause symptoms.
What hormone therapy can do in perimenopause
Perimenopause is a roller coaster. The ovaries still produce estradiol, sometimes in bursts that inflame the breasts and trigger migraines, but ovulation may be sporadic and progesterone low. Here, hormone balancing is as much about evening out peaks and troughs as replacing deficiency. Strategies vary. Some women do well with a low transdermal estradiol patch to stabilize vasomotor symptoms, paired with oral micronized progesterone for sleep and endometrial protection. Others prefer progestin-dominant approaches such as a levonorgestrel IUD to control bleeding, then add estradiol later if hot flashes intensify. The decision hinges on symptom pattern, hormone therapy migraine history, clot risk, and contraceptive needs.
Oral combined HRT works for many, but I often lean on transdermal estrogen in perimenopause. It avoids first-pass liver metabolism, keeps clot risk lower than oral, and allows tighter titration. Micronized progesterone, derived from plant sources but structurally identical to ovarian progesterone, is generally better tolerated than older synthetic progestins. Patients describe deeper sleep and fewer mood swings with it, although individual reactions vary.
Menopause hormone therapy, safety, and the timing question
For hot flashes and night sweats, HRT for menopause is the most effective treatment we have. Within two to four weeks, most women report fewer flashes, steadier sleep, and a calmer nervous system. Over months, estrogen and progesterone therapy also relieve vaginal dryness and pain with penetration, support urethral and bladder health, and slow bone loss.
Safety remains the top concern, and it should. The Women’s Health Initiative, launched more than two decades ago, created appropriate caution and also left confusion in its wake. The most reliable takeaways today look like this. Starting menopause hormone therapy before age 60 or within 10 years of the final period is associated with a more favorable cardiovascular profile than starting later. Transdermal estradiol at standard doses carries a lower risk of venous thrombosis and stroke than oral estrogen. Estrogen alone in women with prior hysterectomy did not increase breast cancer incidence in WHI follow-up, and may have slightly reduced it. Combined estrogen and progestin therapy is associated with a small increase in breast cancer risk with longer use. To put that into plain numbers, the absolute increase with combined therapy is on the order of several additional cases per 1000 women over about 5 years - similar in magnitude to drinking one glass of wine nightly and lower than the risk associated with obesity or physical inactivity.
Risks are not uniform. A woman with a personal clot history, a known thrombophilia, or a strong family pattern of early cardiovascular events needs a tailored approach and often a preference for nonhormonal options. Migraine with aura, uncontrolled hypertension, active liver disease, and a history of estrogen-sensitive malignancy alter the calculus. For severe vasomotor symptoms when systemic therapy is not appropriate, nonhormonal agents work: SSRIs or SNRIs, gabapentin, and the newer neurokinin 3 receptor antagonist class can meaningfully blunt hot flashes.
Delivery routes, in brief
Choosing a route for estrogen and progesterone is not cosmetic. It shapes risk, convenience, and symptom control. Here is how I sketch it at the first visit.
- Transdermal estradiol patch or gel: Steady levels, lower clot risk than oral, easy dose adjustments, adhesive issues in a minority. Oral estradiol: Familiar, inexpensive generics, small increase in clot and stroke risk compared with transdermal, more impact on triglycerides. Vaginal estrogen: Targets genitourinary symptoms with minimal systemic absorption, safe for long-term use at low doses, does not treat hot flashes. Oral micronized progesterone: Good endometrial protection, sleep benefit for some, dizziness if taken in daytime, peanut allergy caution for certain brands. Levonorgestrel IUD as the progestin component: Excellent bleeding control and endometrial protection, local progestin exposure, insertion visit required.
These cover most needs. I mention compounded bioidentical hormones when a patient has a specific intolerance or requires a rare dose not made by manufacturers. Otherwise, I favor FDA-approved bioidentical hormone replacement therapy - estradiol and micronized progesterone - because the dosing is predictable and the safety data are stronger. Compounded hormone therapy can help in edge cases, but potency can vary and the lack of large-scale safety oversight matters. Pellet hormone therapy, heavily marketed as pellet implants, delivers estradiol or testosterone through a minor procedure. Once placed, the dose is not adjustable. Levels can overshoot for months. For that reason, I rarely recommend pellet hormone therapy as a first or even second choice.
Testosterone therapy for women - narrow indication, careful dosing
Testosterone optimization has a large online presence and a narrow clinical niche for women. Evidence supports testosterone treatment for postmenopausal women with hypoactive sexual desire disorder after other contributors have been addressed. The goal is physiologic female-range testosterone, not bodybuilder peaks. When done well, a tiny transdermal dose improves desire and arousal within several weeks. When done poorly - often with hormone injections or pellets designed for men - it leads to acne, scalp hair thinning, voice deepening, clitoral enlargement, and adverse lipid shifts. There is no FDA-approved testosterone product for women in the United States. Clinicians either compound low-dose gels sensitively or carefully adapt male formulations. This is one place where working with a hormone specialist who tracks total and free testosterone, SHBG, and clinical effects over time makes a real difference.
Practical starting points I use
For vasomotor symptoms and sleep disruption in early postmenopause, I often start with a 0.025 to 0.05 mg transdermal estradiol patch twice weekly, paired with oral micronized progesterone 100 mg nightly if the uterus is present. If bleeding breaks through, I will adjust to cyclic progesterone 200 mg nightly for 12 to 14 days each month or consider a levonorgestrel IUD for continuous protection. If genitourinary symptoms drive the visit, local estrogen can be enough - an estradiol tablet twice weekly after a two-week nightly loading phase, or a small dose of estradiol cream two to three times per week. For women worried about libido as systemic estrogen starts, I optimize sleep and pain first, treat vaginal dryness aggressively, and only then consider low-dose testosterone with tight monitoring.
Monitoring is practical. I watch symptoms more than numbers. For transdermal estradiol, routine estradiol blood levels are unnecessary. I track blood pressure, lipids periodically, and encourage weight-bearing exercise and protein targets to protect bone and muscle. Mammography follows screening guidelines. If spotting occurs six months after starting a stable regimen, the endometrium deserves a look. The safest HRT is a well-followed HRT.
Thyroid, adrenal, DHEA, and the allure of “optimization”
It is tempting to throw every hormone at middle-age fatigue. That is how some clinics end up with long menus - thyroid hormone therapy for borderline TSH, DHEA therapy for low energy, cortisol treatment for “adrenal fatigue,” even growth hormone therapy marketed as anti-aging hormone therapy. A steady hand helps here.
True hypothyroidism warrants thyroid hormone replacement. I use levothyroxine and target a TSH in the reference range, adjusting for pregnancy or specific comorbidities. Combination T4/T3 therapy is reasonable in selected, persistently symptomatic patients with careful monitoring, but not a default. DHEA levels fall with age, and small supplemental doses can help sexual function in a minority, yet higher doses convert to androgens and estrogens in unpredictable ways. For cortisol, the term adrenal fatigue is misleading. If cortisol is low due to adrenal insufficiency, that is urgent endocrine treatment, not a wellness tweak. If it is normal, adding cortisol invites weight gain, glucose intolerance, and bone loss. Human growth hormone treatment and IGF-1 therapy have narrow, serious indications. As a longevity hormone therapy for the general population, they create more problems than they solve. The upshot - treat deficiencies, not birthdays.
Special situations that change the HRT playbook
Migraine with aura raises stroke risk slightly, so I prefer transdermal estradiol at the lowest effective dose and often avoid oral estrogen. For a patient with prior venous thrombosis not on anticoagulation, nonhormonal options take the lead. If a woman had endometriosis before menopause, I am more cautious with unopposed estrogen because residual tissue can reactivate; continuous combined regimens or progestin-leaning options make more sense.
For surgical menopause at 35 after oophorectomy, the conversation shifts. Without ovarian hormones, the sudden drop in estradiol and testosterone can be brutal. This is one of the clearest indications for timely estrogen replacement therapy to protect bone, brain, and heart long term, barring a cancer contraindication. Libido changes can be pronounced, and carefully dosed testosterone therapy may be appropriate with close follow up.
In the postpartum stretch, estrogen is low, vaginal tissues are thin, and breastfeeding suppresses ovarian hormones. Local vaginal estrogen is compatible with lactation and can turn painful intercourse into a nonissue. Systemic HRT is not indicated there, but progesterone or SSRI therapy has a role for mood disorders depending on the profile.
For PCOS, the challenge is not deficiency but imbalance - insulin resistance, androgen excess, and irregular ovulation. Hormone imbalance treatment often means cyclic endometrial protection with progestin or combined contraception, insulin sensitizers when appropriate, and weight and strength targets. For endometriosis, progestin-dominant regimens or GnRH modulators quiet tissue activity; postmenopausal systemic estrogen requires a thoughtful, often continuous progestin plan.
Evidence, myths, and the “bioidentical” label
Bioidentical hormones simply means the molecule matches what the body makes. Estradiol and micronized progesterone are bioidentical and available as FDA-approved products. Synthetic hormone therapy refers to older molecules like conjugated equine estrogens or certain progestins that are not identical to human hormones. Outcomes vary more by route and dose than by this label alone. Compounded bioidentical hormones are mixed by a pharmacist to a prescriber’s specification. They can help in niche cases - for example, combining estriol with estradiol for a patient who cannot tolerate standard low-dose vaginal estradiol. Yet, the quality control is not the same as with branded or generic products. When a practice promotes compounded bioidentical hormones as universally safer or “natural hormone replacement” as side-effect free, that is marketing, not medicine.
Nonhormonal stand-ins that genuinely work
Some patients cannot or do not want HRT. The good news is that alternatives exist. Fezolinetant and other neurokinin 3 receptor antagonists reduce hot flashes without touching estrogen receptors. SSRIs and SNRIs help both mood and vasomotor symptoms. Gabapentin helps night sweats and sleep. Vaginal moisturizers and lubricants are underused and effective when used regularly. Pelvic floor physical therapy improves sexual pain and bladder symptoms. Strength training two to three times weekly increases lean mass, steadies blood sugar, and improves almost every menopause complaint indirectly.
When to ask for a specialist
Many primary care clinicians and gynecologists are comfortable with menopause relief treatment. A referral to a hormone doctor or endocrinologist helps when symptoms persist despite reasonable trials, the risk profile is complex, or unusual hormones are under consideration. I also value shared care - for example, menopause management coordinated with an oncologist after breast cancer.
Here is a short, practical checklist I share with patients about seeking a hormone specialist.
- A history of blood clots, stroke, or cardiovascular disease combined with severe vasomotor symptoms. Surgical menopause before 45, especially with distressing libido or mood changes. Persistent bleeding six months into HRT or bleeding after a long period of no menses. Interest in testosterone therapy or compounded bioidentical hormones with nuanced risks. Menopause symptoms in the setting of breast cancer history or active endocrine therapy.
What “balancing” really means
Hormone rebalancing or recalibration are lovely phrases. In practice, they translate to setting priorities, testing judiciously, and making measured adjustments. For a 44-year-old with monthly rage and night sweats, balance might mean luteal-phase progesterone, a structured sleep plan, and iron repletion. For a 52-year-old with 20 hot flashes a day and a mother who broke her hip at 68, it might be transdermal estradiol plus micronized progesterone, calcium from food, and a deadlift lesson. For a 63-year-old with vaginal pain and recurrent UTIs who does not want systemic hormones, it is local estrogen twice weekly, pelvic floor therapy, and a standing prescription for a urinary antiseptic on travel days. Hormone optimization is not one product. It is a sequence of thoughtful choices.
Putting it together with realistic expectations
Expect two to four weeks for vasomotor relief to start, and up to three months for full effect. Expect dose adjustments. Expect that some symptoms - like joint stiffness or brain fog - will improve with better sleep and less thermal chaos, but may also need targeted work. Expect to revisit the plan yearly and after any major health event. Quality HRT is a relationship, not a prescription.
As for longevity claims and regenerative hormone therapy, skepticism serves you well. Estradiol and progesterone can protect bone and reduce fractures, maintain urogenital health, and ease mood and sleep symptoms. Starting near menopause may support cardiovascular health, but HRT is not an insurance policy against heart disease or dementia. Diet, movement, blood pressure, lipids, and social connection carry more weight over decades. Hormones help you build those habits by making you feel like yourself again.
If you are sifting through messages from a hormone clinic that promises instant hormone wellness, translate the offer. The most powerful element they can provide is attentive care paired with evidence-based hormone replacement therapy. Ask about routes and doses. Ask how they protect your endometrium. Ask what their plan is if you spot after six months. A trustworthy clinician will welcome those questions.
The arc from PMS to postmenopause is not a decline, it is a change in operating system. With the right mix of lifestyle measures, nonhormonal supports, and hormone therapy where appropriate, women can move through each phase with clarity and control. The goal is simple - relief from the symptoms that steal your hours, and a plan that protects the bones, brain, and heart that carry you forward.